Finkelstein, Joel S <br/><br/>
Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  Aug 2006 
 - 2882-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0021-972X 
<br/><br/><label>Standard No.: </label>10.1210/jc.2006-0190  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Alendronate--administration & dosage<br/>Bone Density Conservation Agents--administration & dosage<br/>Bone Remodeling--drug effects<br/>Collagen Type I--blood<br/>Humans<br/>Male<br/>Middle Aged<br/>Osteocalcin--blood<br/>Osteoporosis--drug therapy<br/>Peptide Fragments--blood<br/>Peptides--blood<br/>Procollagen--blood<br/>Teriparatide--administration & dosage<br/>Treatment Outcome